WellSpring Pharmaceutical Corporation, a Sarasota, Florida-based manufacturer and marketer of specialty prescription and over-the-counter pharmaceuticals, has been acquired by private equity firm Sentinel Capital Partners.
Ancor Capital Partners also participated in the transaction along with:
– Dr. Robert A. Vukovich, founder and CEO of WellSpring, who reinvested in the company and will serve on its board of directors.
– Ms. Bonnie Feeney, President and COO of Wellspring Pharmaceutical Canada Corporation, and
– Ms. Wendy Shusko, COO and CFO of Wellspring Pharmaceutical Corporation USA.
Ms. Bonnie Feeney and Ms. Wendy Shusko will both continue in their current positions while J. Randall Keene, Managing Partner at Ancor Capital Partners, will serve as CEO of the company.
WellSpring manufactures and distributes prescription drugs and OTC brands through pharmaceutical distributors, wholesalers, and major food and drug retailers. The company also manufactures pharmaceuticals for other drug companies on a contract basis in its production facility in Ontario, Canada.